CUAMC
ACAD icon

China Universal Asset Management Company’s Acadia Pharmaceuticals ACAD Stock Holding History

China Universal Asset Management Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689K Sell
27,252
-3,004
-10% -$66.1K 0.04% 238
2026
Q1 		$673K Buy
30,256
+2,688
+10% +$64.2K 0.05% 238
2025
Q4 		$736K Sell
27,568
-2,005
-7% -$47.9K 0.06% 213
2025
Q3 		$631K Sell
29,573
-4,041
-12% -$95.6K 0.05% 221
2025
Q2 		$725K Buy
33,614
+159
+0.5% +$2.96K 0.07% 211
2025
Q1 		$556K Sell
33,455
-1,826
-5% -$33.2K 0.05% 240
2024
Q4 		$647K Buy
35,281
+3,378
+11% +$54.5K 0.06% 216
2024
Q3 		$491K Buy
31,903
+12,493
+64% +$208K 0.05% 220
2024
Q2 		$315K Sell
19,410
-12,244
-39% -$198K 0.04% 185
2024
Q1 		$585K Buy
31,654
+12,669
+67% +$314K 0.07% 170
2023
Q4 		$594K Buy
18,985
+14,783
+352% +$353K 0.12% 135
2023
Q3 		$87.6K Buy
4,202
+2,070
+97% +$56.2K 0.03% 201
2023
Q2 		$51.1K Sell
2,132
-66
-3% -$1.47K 0.02% 189
2023
Q1 		$41.4K Buy
2,198
+553
+34% +$10.5K 0.01% 164
2022
Q4 		$26.2K Buy
1,645
+130
+9% +$2.03K 0.01% 162
2022
Q3 		$25K Buy
+1,515
New +$24.5K 0.01% 143

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

China Universal Asset Management Company's ACAD Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Acadia Pharmaceuticals (ACAD) stake by 9.9% in Q2 2026, selling an estimated $66.1K and leaving 27,252 shares worth $689K. The position accounts for 0.04% of the portfolio, ranked #238.

China Universal Asset Management Company first reported a position in ACAD in Q3 2022 and has held it in 16 quarters since. The position peaked at $736K in Q4 2025. 354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • China Universal Asset Management Company held 27,252 shares of Acadia Pharmaceuticals worth $689K as of Q2 2026.
  • China Universal Asset Management Company sold 3,004 Acadia Pharmaceuticals shares in Q2 2026, an estimated $66.1K.
  • Acadia Pharmaceuticals made up 0.04% of China Universal Asset Management Company's portfolio in Q2 2026, its #238 holding.
  • China Universal Asset Management Company first reported a position in Acadia Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • China Universal Asset Management Company's Acadia Pharmaceuticals position peaked at $736K in Q4 2025.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.